Complement activation in patients with acute myocardial infarction treated with streptokinase

American Journal of the Medical Sciences

Volumn 315, Issue 1, 1998, Pages 24-29

  Oren, Shmuel ^a   Maslovsky, Igor ^a   Schlesinger, Menachem ^a   Reisin, Leonardo ^a,b,c  

^a Department of Internal Medicine ^*  (Israel)

^b BARZILAI MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute myocardial infarction; Complement; Streptokinase

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT COMPONENT C4D; COMPLEMENT COMPONENT C5B; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; MALE;

EID: 0031984239     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199801000-00005     Document Type: Article

References (22)

1. Muscari A, Bozzoli D, Gerratana C, et al. Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis. 1988; 74:179-86.
2. Muscari A, Bozzoli C, Puddu GM, et al. Association of serum C3 levels with the risk of myocardial infarction. Am J Med. 1995; 98:357-64.
3. Vakeva A, Morgan BP, Tikkanen I, Helin K, Laurila P, Meri S. Time course of complement activation and inhibitor expression after ischémie injury of rat myocardium. Am J Pathol. 1994;144(6):1357-68.
4. Shafer HJ, Mathey D, Hugo F, Bakhdi S. Deposition of the terminal C5b-9 complement complex in infarcted area of myocardium. J Immunol. 1986; 137:1945-9.
5. Rossen RD, Michael LH, Kagiyama A, et al. Mechanism of complement activation after coronary artery occlusion: Evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human Clq in vivo. Circ Res. 1988;62:572-84.
6. Yasuda M, Takeuchi K, Hiruma M, lida H, Tahara A, Itagane H, et al. The complement system in ischémie heart disease. Circulation. 1990;81(l):156-63.
7. Bennett WR, Yawn DH, Migliore PJ, Young J, Pratt C, Raizner A, et al. Activation of the complement system by recombinant tissue plasminogen activator. J Am Coll Cardiol. 1987; 10:627-32.
8. Mollnes TE, Tambs KE, Myreng Y, Engebretsen LF. Acute phase reactant and complement activation in patients with acute myocardial infarction. Complement. 1988; 5:33-9.
9. Sundsmo JS, Fair DS. Relationships among the complement, kinin, coagulation and fibrinolytic system in the inflammatory reaction. Clin Physiol Biochem. 1983; 1:255-84.
10. Frangi D, Cardinal! M, Conciato L, Cafaro C, Pozzoni L, Agostoni A. Abrupt complement activation and transitory neutropenia in patients with acute myocardial infarction treated with streptokinase. Circulation. 1994;89(1):76-80.
11. Freysdottir J, Ormarsdottir S, Sigfusson A. Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase. Clin Exp Immunol. 1993; 94:286-90.
12. Fernandez AR, Sequeira RF, Chakko S, Correa LF, deMarchena E J, Chahine RA, et al. ST segment tracking for rapid determination of patency of the infarct-related artery in acute myocardial infarction. J Am Coll Cardiol. 1995;26: 675-83.
13. Ottani F, Galvani M, Ferrini C, Sorgello F, Limonetti P, Pantoli D, et al. Prodromal angina limits infarct size: A role for ischémie preconditioning. Circulation. 1995;92:1061-2.
14. Langlois PF, Gawryl MS. Detection of the terminal complement complex in patients' plasma following acute myocardial infarction. Atherosclerosis. 1988;70:95-105.
15. Agostoni A, Gardinali M, Fragi D, Cafaro C, Conciato L, Sponzilli C, et al. Activation of complement and kinin system after thrombolytic therapy in patients with acute myocardial infarction: A comparison between streptokinase and recombinant tissue-type plasminogen activator. Circulation. 1994;90(6):2666-70.
16. Mathey D, Schofer J, Schafer H, Hamdoch T, Jochim H, Ritgen A, et al. Early accumulation of the terminal complement-complex in the ischémie myocardium after reperfusion. Eur Heart J. 1994;15(3):418-23.
17. Shaila G, Chandrashekhar YS, Kumar N, Ganguly NK, Anand IS. Antistreptokinase antibodies before and after streptokinase therapy in patients with acute myocardial infarction from areas endemic for streptococcal infection and influence on reperfusion rates. Am J Cardiol. 1994; 74(2): 187-9.
18. Lagrand WK, Niessen HW, Wolbink GJ, Jaspars LH, Visser ÇA, Verbeugt FW, ct al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation. 1997;95(1):97-103.
19. Schaiff WT, Eisenberg PR. Direct induction of complement activation by pharmacologie activation of plasminogen. Coron Artery Dis. 1997;8(1):9-18.
20. Bosker HA, van der Laarse A, Cats VM, Bruschkc AV. Are enzymatic tests good indicators of coronary reperfusion? Br Heart J. 1992;67:150-4.
21. Gressin V, Louvard Y, Pezzano M, Lardoux H. Holler recording of ventricular arrhythmias during intravenous thrombolysis for acute myocardial infarction. Am J Cardiol. 1992;69(3):152-9.
22. Weiser MR, Williams JP, Moore FD Jr, Kobzik J, Ma M, Hechtman HB, Carroll MC. Reperfusion injury of ischémie skeletal muscle is mediated by natural antibody and complement. Mol Immunol. 1996;307:33.